The current analyst and expert consensus on HealthEquity is Buy, with 9 strong buy opinions. The current projected HealthEquity target price consensus is 85.18 with 11 analyst opinions. Check out Macroaxis Advice on HealthEquity to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.The most common way HealthEquity analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview HealthEquity executives and customers to further validate their buy or sell advice. HealthEquity buy-or-sell recommendation module provides average expert sentiment on the projected HealthEquity target price to derive its highest and lowest estimates based on projected price volatility of 4.915.
Gross Profit is likely to rise to about 528.8 M in 2023, whereas Profit Margin is likely to drop (0.0308) in 2023. At this time, HealthEquity's Investments Current are fairly stable as compared to the past year. . Total Liabilities is likely to rise to about 1.3 B in 2023, whereas Accumulated Other Comprehensive Income is likely to drop (261.2 K) in 2023.
It's important to approach HealthEquity's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
HealthEquity Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. HealthEquity target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. HealthEquity's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
HealthEquity Target Price ProjectionHealthEquity's current and average target prices are 69.39 and 85.18, respectively. The current price of HealthEquity is the price at which HealthEquity is currently trading. On the other hand, HealthEquity's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.
HealthEquity Market Quote on 4th of December 2023
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on HealthEquity and the information provided on this page.
Analyst Consensus On HealthEquity Target Price
HealthEquity Analyst RatingsHealthEquity's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about HealthEquity stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of HealthEquity's financials, market performance, and future outlook by experienced professionals. HealthEquity's historical ratings below, therefore, can serve as a valuable tool for investors.
Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize HealthEquity price targetsHealthEquity's stock target price is an estimate of its future price, usually made by analysts. Using HealthEquity's target price to determine if it is a suitable investment can be done through the following steps:
- Look at HealthEquity's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if HealthEquity's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional HealthEquity Value Projection ModulesMost investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of HealthEquity is a key component of HealthEquity valuation and have some predictive power on the future returns of a HealthEquity.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of HealthEquity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of HealthEquity in the context of predictive analytics.
Trending ThemesIf you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Macroaxis Advice on HealthEquity to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
The data published in HealthEquity's official financial statements usually reflect HealthEquity's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of HealthEquity. For example, before you start analyzing numbers published by HealthEquity accountants, it's critical to develop an understanding of what HealthEquity's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of HealthEquity's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HealthEquity's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Please utilize our Beneish M Score to check the likelihood of HealthEquity's management manipulating its earnings.